Massachusetts Financial Services’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.5M Sell
311,649
-15,553
-5% -$988K 0.01% 639
2025
Q4
$20.8M Sell
327,202
-169,471
-34% -$10.5M 0.01% 639
2025
Q3
$27.3M Sell
496,673
-929
-0.2% -$38.3K 0.01% 585
2025
Q2
$16.4M Buy
497,602
+178,069
+56% +$6.19M 0.01% 641
2025
Q1
$12.8M Buy
319,533
+252
+0.1% +$11.6K ﹤0.01% 641
2024
Q4
$15M Sell
319,281
-25,167
-7% -$1.31M ﹤0.01% 631
2024
Q3
$18.2M Buy
344,448
+68,381
+25% +$3.81M 0.01% 604
2024
Q2
$15M Buy
+276,067
New +$16.7M ﹤0.01% 607

Other funds holding CYTK